Johnson & Johnson JNJ

Johnson & Johnson is a publicly traded company listed on NYSE under the ticker JNJ. Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was foun

Johnson & Johnson (JNJ) is trading at $225.33, down 2.37% on the day. Prices on this page update through the trading session. This is not financial advice.

Wall Street analysts currently rate JNJ a consensus "Buy", with an average 12-month price target of $252.96 (+12.26% vs the current price). Ratings are opinions, not guarantees — always do your own research.

The next Johnson & Johnson earnings date is around Jul 15, 2026. Earnings dates can move — check the company's investor relations page to confirm.

Johnson & Johnson pays a dividend with a current yield of about 2.38% ($5.36 per share annually).